Please ensure Javascript is enabled for purposes of website accessibility

Cancer startup wins $5,000 Maryland Tech Council pitch competition

Remedy Plan Therapeutics won the start-up pitch contest at The Maryland Tech Council’s Bio+Tech18. Pictured with a ceremonial check are, from left, Rene LaVigne, Maryland Tech Council board director; Greg Crimmins, CEO of Remedy Plan Therapeutics and Bio+Tech18 pitch contest winner; Jeff Galvin, CEO of American Gene and Bio+Tech18 pitch contest sponsor; and Bret Schreiber, senior director, Office of BioHealth and Life Sciences, Maryland Department of Commerce. (Submitted photo)

Remedy Plan Therapeutics won the start-up pitch contest at The Maryland Tech Council’s Bio+Tech18. Pictured with a ceremonial check are, from left, Rene LaVigne, Maryland Tech Council board director; Greg Crimmins, CEO of Remedy Plan Therapeutics and Bio+Tech18 pitch contest winner; Jeff Galvin, CEO of American Gene and Bio+Tech18 pitch contest sponsor; and Bret Schreiber, senior director, Office of BioHealth and Life Sciences, Maryland Department of Commerce. (Submitted photo)

Remedy Plan Therapeutics won the startup pitch contest at the Maryland Tech Council’s Bio+Tech18 conference in Baltimore, the council announced.

The council on Thursday awarded $5,000 to Remedy Plan, a Rockville company that is working on drugs that target cancer stem cells to hold back tumor growth.

Remedy Plan and four other finalists, AlgometRx, JuneBrain, Sonavex and VakSea, pitched attendees and judges during a cocktail reception Thursday.

Marty Rosendale, CEO of the council, said the contest was a success, and that the council achieved its goal of highlighting innovation in Maryland’s technology and life science businesses.

 


To purchase a reprint of this article, contact [email protected].